Logo image of DSFIR.AS

DSM-FIRMENICH AG (DSFIR.AS) Stock Fundamental Analysis

AMS:DSFIR - Euronext Amsterdam - CH1216478797 - Common Stock - Currency: EUR

95.76  +0.28 (+0.29%)

Fundamental Rating

4

DSFIR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 69 industry peers in the Chemicals industry. The financial health of DSFIR is average, but there are quite some concerns on its profitability. While showing a medium growth rate, DSFIR is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

DSFIR had positive earnings in the past year.
In the past year DSFIR had a positive cash flow from operations.
DSFIR.AS Yearly Net Income VS EBIT VS OCF VS FCFDSFIR.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 500M 1B 1.5B 2B

1.2 Ratios

With a Return On Assets value of 0.74%, DSFIR perfoms like the industry average, outperforming 46.38% of the companies in the same industry.
DSFIR has a Return On Equity (1.11%) which is comparable to the rest of the industry.
DSFIR has a worse Return On Invested Capital (0.87%) than 62.32% of its industry peers.
Industry RankSector Rank
ROA 0.74%
ROE 1.11%
ROIC 0.87%
ROA(3y)5.56%
ROA(5y)N/A
ROE(3y)8.73%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DSFIR.AS Yearly ROA, ROE, ROICDSFIR.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 5 10 15

1.3 Margins

DSFIR has a Profit Margin of 3.83%. This is in the better half of the industry: DSFIR outperforms 60.87% of its industry peers.
In the last couple of years the Profit Margin of DSFIR has declined.
DSFIR has a Operating Margin of 5.95%. This is comparable to the rest of the industry: DSFIR outperforms 55.07% of its industry peers.
DSFIR's Operating Margin has declined in the last couple of years.
DSFIR has a Gross Margin of 65.10%. This is amongst the best in the industry. DSFIR outperforms 97.10% of its industry peers.
In the last couple of years the Gross Margin of DSFIR has declined.
Industry RankSector Rank
OM 5.95%
PM (TTM) 3.83%
GM 65.1%
OM growth 3Y-15.02%
OM growth 5YN/A
PM growth 3Y-36.48%
PM growth 5YN/A
GM growth 3Y-3.22%
GM growth 5YN/A
DSFIR.AS Yearly Profit, Operating, Gross MarginsDSFIR.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 10 20 30

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DSFIR is destroying value.
DSFIR has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for DSFIR is higher compared to a year ago.
DSFIR.AS Yearly Shares OutstandingDSFIR.AS Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 50M 100M 150M 200M 250M
DSFIR.AS Yearly Total Debt VS Total AssetsDSFIR.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 10B 20B 30B

2.2 Solvency

DSFIR has an Altman-Z score of 2.18. This is not the best score and indicates that DSFIR is in the grey zone with still only limited risk for bankruptcy at the moment.
DSFIR's Altman-Z score of 2.18 is in line compared to the rest of the industry. DSFIR outperforms 52.17% of its industry peers.
DSFIR has a debt to FCF ratio of 5.21. This is a neutral value as DSFIR would need 5.21 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.21, DSFIR is in the better half of the industry, outperforming 69.57% of the companies in the same industry.
A Debt/Equity ratio of 0.20 indicates that DSFIR is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.20, DSFIR is doing good in the industry, outperforming 73.91% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 5.21
Altman-Z 2.18
ROIC/WACC0.19
WACC4.46%
DSFIR.AS Yearly LT Debt VS Equity VS FCFDSFIR.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

A Current Ratio of 2.02 indicates that DSFIR has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.02, DSFIR is doing good in the industry, outperforming 62.32% of the companies in the same industry.
DSFIR has a Quick Ratio of 1.26. This is a normal value and indicates that DSFIR is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.26, DSFIR is doing good in the industry, outperforming 65.22% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.02
Quick Ratio 1.26
DSFIR.AS Yearly Current Assets VS Current LiabilitesDSFIR.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2B 4B 6B 8B

4

3. Growth

3.1 Past

The earnings per share for DSFIR have decreased strongly by -89.70% in the last year.
The earnings per share for DSFIR have been decreasing by -45.42% on average. This is quite bad
Looking at the last year, DSFIR shows a very strong growth in Revenue. The Revenue has grown by 20.44%.
DSFIR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.80% yearly.
EPS 1Y (TTM)-89.7%
EPS 3Y-45.42%
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)20.44%
Revenue growth 3Y3.8%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, DSFIR will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.25% on average per year.
Based on estimates for the next years, DSFIR will show a small growth in Revenue. The Revenue will grow by 3.42% on average per year.
EPS Next Y33.33%
EPS Next 2Y19.8%
EPS Next 3Y17.29%
EPS Next 5Y12.25%
Revenue Next Year2.68%
Revenue Next 2Y3.05%
Revenue Next 3Y3.67%
Revenue Next 5Y3.42%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
DSFIR.AS Yearly Revenue VS EstimatesDSFIR.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B
DSFIR.AS Yearly EPS VS EstimatesDSFIR.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 101.87, DSFIR can be considered very expensive at the moment.
62.32% of the companies in the same industry are cheaper than DSFIR, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.32, DSFIR is valued quite expensively.
A Price/Forward Earnings ratio of 22.11 indicates a rather expensive valuation of DSFIR.
DSFIR's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.19. DSFIR is around the same levels.
Industry RankSector Rank
PE 101.87
Fwd PE 22.11
DSFIR.AS Price Earnings VS Forward Price EarningsDSFIR.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

DSFIR's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DSFIR indicates a somewhat cheap valuation: DSFIR is cheaper than 65.22% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 25.09
EV/EBITDA 15.34
DSFIR.AS Per share dataDSFIR.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
DSFIR's earnings are expected to grow with 17.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.06
PEG (5Y)N/A
EPS Next 2Y19.8%
EPS Next 3Y17.29%

2

5. Dividend

5.1 Amount

DSFIR has a Yearly Dividend Yield of 2.60%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.00, DSFIR pays a bit more dividend than its industry peers.
DSFIR's Dividend Yield is comparable with the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 2.6%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
DSFIR.AS Yearly Dividends per shareDSFIR.AS Yearly Dividends per shareYearly Dividends per share 2024 2025 0.5 1 1.5 2

5.3 Sustainability

266.80% of the earnings are spent on dividend by DSFIR. This is not a sustainable payout ratio.
DP266.8%
EPS Next 2Y19.8%
EPS Next 3Y17.29%
DSFIR.AS Yearly Income VS Free CF VS DividendDSFIR.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 500M 1B 1.5B 2B
DSFIR.AS Dividend Payout.DSFIR.AS Dividend Payout, showing the Payout Ratio.DSFIR.AS Dividend Payout.PayoutRetained Earnings

DSM-FIRMENICH AG

AMS:DSFIR (6/17/2025, 7:00:00 PM)

95.76

+0.28 (+0.29%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)04-30 2025-04-30
Earnings (Next)07-31 2025-07-31
Inst Owners25.14%
Inst Owner ChangeN/A
Ins Owners9.64%
Ins Owner ChangeN/A
Market Cap25.44B
Analysts82.58
Price Target128.57 (34.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.6%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP266.8%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.51%
PT rev (3m)-3.39%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0.38%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.88%
Valuation
Industry RankSector Rank
PE 101.87
Fwd PE 22.11
P/S 3.9
P/FCF 25.09
P/OCF 14.31
P/B 1.13
P/tB 5.74
EV/EBITDA 15.34
EPS(TTM)0.94
EY0.98%
EPS(NY)4.33
Fwd EY4.52%
FCF(TTM)3.82
FCFY3.99%
OCF(TTM)6.69
OCFY6.99%
SpS24.54
BVpS84.73
TBVpS16.69
PEG (NY)3.06
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.74%
ROE 1.11%
ROCE 1.32%
ROIC 0.87%
ROICexc 0.95%
ROICexgc 2.96%
OM 5.95%
PM (TTM) 3.83%
GM 65.1%
FCFM 15.55%
ROA(3y)5.56%
ROA(5y)N/A
ROE(3y)8.73%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-15.02%
OM growth 5YN/A
PM growth 3Y-36.48%
PM growth 5YN/A
GM growth 3Y-3.22%
GM growth 5YN/A
F-Score6
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 5.21
Debt/EBITDA 2.44
Cap/Depr 53.43%
Cap/Sales 11.72%
Interest Coverage 5.79
Cash Conversion 97.8%
Profit Quality 405.6%
Current Ratio 2.02
Quick Ratio 1.26
Altman-Z 2.18
F-Score6
WACC4.46%
ROIC/WACC0.19
Cap/Depr(3y)68.18%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.69%
Cap/Sales(5y)N/A
Profit Quality(3y)150.6%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-89.7%
EPS 3Y-45.42%
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y33.33%
EPS Next 2Y19.8%
EPS Next 3Y17.29%
EPS Next 5Y12.25%
Revenue 1Y (TTM)20.44%
Revenue growth 3Y3.8%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year2.68%
Revenue Next 2Y3.05%
Revenue Next 3Y3.67%
Revenue Next 5Y3.42%
EBIT growth 1Y226.7%
EBIT growth 3Y-11.79%
EBIT growth 5YN/A
EBIT Next Year140.16%
EBIT Next 3Y38.54%
EBIT Next 5Y24.3%
FCF growth 1Y74.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y40.55%
OCF growth 3YN/A
OCF growth 5YN/A